Mammoth Biosciences: valuation, funding, and the secondary tape

The short version

instrumentvalueas ofsource
Claimed valuationn/asource
Napkin: new-money stake7.7% ($107.70M of $1.40B)2024-04-01source

105 Clarity prints since 2026-06-24

Recent milestones

marks table | napkin table | the scorecard | all companies

Derived from the SOMEN graph at render time. The arithmetic cannot lobby you.